Hintner H, Tappeiner G, Gschnait F, Schwarz S, Wolff K
Dtsch Med Wochenschr. 1979 Sep 7;104(36):1269-73. doi: 10.1055/s-0028-1129082.
Danazol, an attenuated androgen, was administered to four patients with hereditary angioneurotic oedema, with rapid and complete response without side-effects. The follow-up period has now been up to 17 months. In all patients there was an indirect indication that their hormonal state influenced the course of the disease.